Name | Description | Industry | Official Website | Location | ||
---|---|---|---|---|---|---|
Autolus is a biopharmaceutical company focused on programmed T-cell therapies for treatment of cancer. Autolus was founded in 2014 and is based in London, UK. Autolus Limited is a subsidiary of Autolus Holdings (UK) Limited. | ||||||
Artios Pharma develops cancer treatments that target DNA Damage Response (DDR) Pathways to selectively kill cancer cells | ||||||
GenSight Biologics is a clinical-stage biotechnology company discovering and developing novel therapies for neurodegenerative retinal diseases and diseases of the central nervous system. | ||||||
Disc Medicine is a medical research company that develops treatments for hematologic diseases. | ||||||
Estate agency using data to help customers buy homes without being part of a property chain. | ||||||
Imara is a Cambridge, Massachusetts-based biotechnology company. | ||||||
LogicBio Therapeutics is a Cambridge, Massachusetts-based biotechnology company. | ||||||
Amplyx Pharmaceuticals, Inc. is a preclinical stage company focusing on the development of small molecule drugs. | ||||||
Iterum Therapeutics is an Ireland-based pharmaceutical manufacturing company developing differentiated anti-infectives. | ||||||
Harpoon Therapeutics is a t cell recruiting antibodies founded in 2015. | ||||||
PreciThera, Inc. is a biotech company that is positioned to develop therapies for bone diseases. | ||||||
Small Molecules Modulating Tumor Microenvironment |